Content about LISBON

September 16, 2011

BI, Lilly drug reduces blood sugar over long term

A drug made by Boehringer Ingelheim and Eli Lilly showed "meaningful and durable" reductions in blood sugar in adults with Type 2 diabetes, according to results of a late-stage clinical trial presented Friday at a conference in Europe.

September 13, 2011

Study: Sanofi insulin reduces weight gain, increases blood sugar control

An insulin analogue made by Sanofi appears to work better in certain cases than competing treatments at reducing weight gain and controlling blood sugar among patients with Type 2 diabetes.

September 12, 2011

Studies: Bydureon shows improvements in cardiovascular health

Patients treated with a long-acting drug for Type 2 diabetes experienced a reduction in cardiovascular health risk factors, according to results of a study presented at the European Association for the Study of Diabetes' annual meeting.

September 8, 2011

Boehringer Ingelheim, Eli Lilly present data from studies of diabetes drugs

Boehringer Ingelheim and Eli Lilly will present data from their diabetes portfolio at the 47th Annual Meeting of the European Association for the Study of Diabetes in Lisbon, Portugal.

October 4, 2010

AccuDial presents possible solution to overdosage of OTC medication

Parents’ confusion over correctly administering over-the-counter medication to their children appears to be shared worldwide,...

August 29, 2010

Survey finds pharmacists' role in health care is evolving

Pharmacists' role has significantly changed, with more than 90% of pharmacists believing they are key...